AQEMIA
AQEMIA, a leading company in generative-AI-driven drug discovery, announces the achievement of a research milestone in its collaboration with Servier, an international independent pharmaceutical company, to address an undruggable target in immuno-oncology.
Based on AQEMIA ‘s quantum and statistical physics-based calculations, and within the span of a few months, a series of molecules experimentally active on an undruggable target in immuno-oncology have been successfully identified. This milestone triggers an undisclosed payment to AQEMIA.
"Our teams are very proud of this achievement that demonstrates the power of AQEMIA's cutting-edge generative AI and deep physics in creating novel, patentable molecules to meet therapeutic needs that are still immense, particularly in the field of immuno-oncology. Within the framework of our collaboration with Servier, we have reached the stage where a series of molecules are subsequently proven impactful in vitro and in vivo assays. " said Maximilien Levesque, PhD, CEO and Co-founder of AQEMIA.
This critical milestone is a continuation of Servier and AQEMIA’s successful partnership program, initiated in December 2021, to accelerate drug candidate discovery in immuno-oncology using artificial intelligence and deep physics.
AQEMIA has worked on more than a dozen in-house therapeutic programs in oncology and immuno-oncology, as well as in new therapeutic areas such as immunology, inflammation and diseases of the central nervous system. To date, AQEMIA’s three most advanced programs are being tested against cancers in animals.
About AQEMIA
AQEMIA is a next-gen techbio generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast many innovative drug candidates for critical diseases. Our differentiation lies in our unique quantum and statistical mechanics algorithms to power a generative artificial intelligence designing novel drug candidates, without the need to train on experimental data. We already delivered several drug discovery successes in internal pipeline as well as in collaboration with Pharma companies - most advanced programs being currently in vivo optimization.
For more information, visit AQEMIA.com and our LinkedIn
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240627468833/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ChipAgents Raises Oversubscribed $21M Series A to Redefine AI for Chip Design21.10.2025 16:30:00 CEST | Press release
Sales 50x YoY, Deployments at 50 leading semiconductor companies. Former CEOs of Cadence and Mentor Graphics, Plus Former Synopsys CTO, Join Advisory Board. Today ChipAgents, the agentic AI platform transforming chip design and verification, announced the close of a $21 million Series A funding round, bringing the total fundraise to $24 million to date. This latest round closed with Bessemer Venture Partners, with strategic backing from Micron, MediaTek, Ericsson, and additional top semiconductor companies. Also participating in the round are notable angels including new advisors, Wally Rhines, Raúl Camposano,and Jack Harding, and existing support by ScOp Venture Capital (Ivan Bercovich) and Amino Capital, fueling the company’s expansion of product development, customer acquisition, and strategic industry partnerships. ChipAgents’ mission is to bring the power of AI to the heart of chip design and verification. Every engineer should be empowered with tools that make the most complex as
STARLIMS Launches QM Essentials LIMS, the Best Cloud LIMS for SMB Batch Manufacturing21.10.2025 15:13:00 CEST | Press release
STARLIMS, a global leader in Laboratory Information Management Systems (LIMS) and informatics solutions, today announced Quality Manufacturing (QM) Essentials, a new cloud-based LIMS developed for small and mid-sized (SMB) batch manufacturers to bring products to market quickly and more cost-effectively. The launch reflects STARLIMS’ commitment to meeting the unique needs of smaller batch manufacturing organizations who need the power of a LIMS without the cost or complexity of a large-scale implementation. Built for pharmaceutical, food & beverage, and consumer product industries, QM Essentials allows SMBs to simplify compliance and expedite batch release with an out-of-the-box solution that can be deployed in as little as 4-6 weeks. A Cost-Effective SaaS LIMS with Less Complexity Pre-configured and pre-loaded with essential features such as batch login, environmental monitoring, outsource samples, and static data, QM Essentials is a Software-as-a-Service (SaaS) LIMS that allows SMB l
Lenovo Unlocks New Level of Productivity and Creativity with Copilot+ PCs Powered by AMD Ryzen™ AI Processors21.10.2025 15:00:00 CEST | Press release
Selection of ThinkCentre neo desktops ready to take small and medium-sized businesses into the next era of AI performance Lenovo™ unveiled its new generation of ThinkCentre™ desktop next-gen AI PCs powered by AMD Ryzen™ AI 300 Series processors with up to 50 TOPS of integrated NPU capability: the streamlined ThinkCentre neo 55a Gen 6 all-in-one (AIO), the small form factor ThinkCentre neo 55s Gen 6, and the tiny ThinkCentre neo 55q Gen 6. Designed for small and medium-sized businesses looking to supercharge their productivity with AI, the ThinkCentre neo Gen 6 desktop family offers unique Copilot+ PC experiences1, the performance to excel, the flexibility and expandability to adapt, and the efficiency and support for peace of mind. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251021383117/en/ ThinkCentre™ desktop next-gen AI PCs powered by AMD Ryzen™ AI 300 Series processors “AI has, is, and will continue to reshape the wa
Hologic to be Acquired by Blackstone and TPG for up to $79 per Share21.10.2025 14:41:00 CEST | Press release
Hologic Stockholders to Receive $76 per Share in Cash Plus a Contingent Value Right of up to $3 per Share Payable Upon Achieving Certain Revenue MilestonesRepresents 46% Premium to Hologic’s Closing Price on Last Trading Day Prior to Media Reports of Possible TransactionTransaction Includes Significant Minority Investments from ADIA and GICTransaction Will Help Hologic Strengthen its Leadership in Women’s Health and Accelerate Growth Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into a definitive agreement to be acquired by funds managed by Blackstone (“Blackstone”) and TPG in a transaction valued at up to $79 per share, representing an enterprise value of up to $18.3 billion.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251021765122/en/ Under the terms of the agreement, Blackstone and TPG will acquire all outstanding Hologic shares for $76 per share in cash plus a non-tradable contingent value right (C
Axelera Announces Europa AIPU, Setting New Industry Benchmark for AI Accelerator Performance, Power Efficiency and Affordability21.10.2025 14:00:00 CEST | Press release
Delivers 629 TOPs processing power for multi-modal AI applications from the edge to the data center Axelera AI, the leading provider of purpose-built AI hardware acceleration technology, today announced Europa™, an AI processor unit (AIPU) that sets a new performance/price standard for multi-user generative AI and computer vision applications. Europa’s combination of processing power, energy and thermal efficiency, compact packaging, and multiple form factor options make it ideal for compute-intensive, multi-modal AI inference applications from the edge to enterprise servers. Designed to be cost effective and accessible, Europa enables any organization to unlock the power of cutting-edge AI applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251021493990/en/ Europa™ AIPU Next Gen Architecture for Real World AI Processing Power The Europa AIPU features eight second-generation AI cores, each incorporating Axelera’s ad
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom